NL6610013A - - Google Patents
Info
- Publication number
- NL6610013A NL6610013A NL6610013A NL6610013A NL6610013A NL 6610013 A NL6610013 A NL 6610013A NL 6610013 A NL6610013 A NL 6610013A NL 6610013 A NL6610013 A NL 6610013A NL 6610013 A NL6610013 A NL 6610013A
- Authority
- NL
- Netherlands
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
- A61K39/187—Hog cholera virus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/525—Virus
- A61K2039/5254—Virus avirulent or attenuated
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
- A61K2039/552—Veterinary vaccine
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
- C12N2770/00011—Details
- C12N2770/24011—Flaviviridae
- C12N2770/24311—Pestivirus, e.g. bovine viral diarrhea virus
- C12N2770/24334—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Virology (AREA)
- Microbiology (AREA)
- Immunology (AREA)
- Medicinal Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Mycology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US48051765A | 1965-08-17 | 1965-08-17 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| NL6610013A true NL6610013A (es) | 1967-02-20 |
Family
ID=23908262
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NL6610013A NL6610013A (es) | 1965-08-17 | 1966-07-15 |
Country Status (2)
| Country | Link |
|---|---|
| US (1) | US3422188A (es) |
| NL (1) | NL6610013A (es) |
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| NL7803891A (en) * | 1978-04-12 | 1979-10-16 | Merck & Co Inc | Preservatives for vaccines - contg. hydrolysed gelatin, sorbitol, culture medium and a buffer at pH 6-6.5 |
| EP0351901A1 (en) * | 1988-06-23 | 1990-01-24 | Centraal Diergeneeskundig Instituut | Swine kidney cell culture, and its use in vaccine production |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4147772A (en) * | 1976-02-03 | 1979-04-03 | Merck & Co., Inc. | Vaccine stabilizer |
| US4338335A (en) * | 1980-02-05 | 1982-07-06 | Merck & Co., Inc. | Vaccine stabilizer containing L-glutamic acid and L-arginine |
| US4537769A (en) * | 1982-04-06 | 1985-08-27 | American Cyanamid Company | Stabilization of influenza virus vaccine |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US2518978A (en) * | 1946-09-12 | 1950-08-15 | American Cyanamid Co | Hog cholera vaccine |
| US2594180A (en) * | 1949-04-26 | 1952-04-22 | Fort Dodge Lab Inc | Vaccine and process for manufacturing the same |
| US3014843A (en) * | 1955-02-07 | 1961-12-26 | Armour & Co | Method of producing non-virulent strains of attenuated and stabilized hog cholera virus |
| US3226296A (en) * | 1963-04-05 | 1965-12-28 | Cutter Lab | Attenuated hog cholera virus vaccine and method of producing same |
-
1965
- 1965-08-17 US US480517A patent/US3422188A/en not_active Expired - Lifetime
-
1966
- 1966-07-15 NL NL6610013A patent/NL6610013A/xx unknown
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| NL7803891A (en) * | 1978-04-12 | 1979-10-16 | Merck & Co Inc | Preservatives for vaccines - contg. hydrolysed gelatin, sorbitol, culture medium and a buffer at pH 6-6.5 |
| EP0351901A1 (en) * | 1988-06-23 | 1990-01-24 | Centraal Diergeneeskundig Instituut | Swine kidney cell culture, and its use in vaccine production |
Also Published As
| Publication number | Publication date |
|---|---|
| US3422188A (en) | 1969-01-14 |